We want to offer guidance and services that provide tools to ease completion of research in Denmark.
The aim is to create a joint infrastructure within the field of biobanks. Internationally seen Denmark has a strong position in this field. The strong position is partly due to a long tradition of close collaboration between private companies and public hospitals I Denmark. Bio- and Genome Bank Denmark wants to contribute to strengthened the collaboration between hospitals and companies further and ensure that we have an even more targeted treatment of patients.
An area that is particularly of interest in the public-private collaboration is development of so-called “biomarkers”. Biomarkers can show whether a patient will benefit of a given medical treatment. Bio- and Genome Bank Denmark wants to assist researchers interested in biomarkers with required facilities.
Further readings (in Danish only):
- Paper of principles
- Members of the Steering Committee
- Organization diagram
- Instructions for collaborations with companies (vejledning for samarbejde med virksomheder)
NATIONAL COLLABORATION BETWEEN BIOBANKS
In 2009, the Danish Cancer Biobank (DCB) was founded based on a rapport form The Danish Cancer Society from 2005.
The Danish Regions decided to establish the Danish Reuma Biobank (DRB) in 2014 and in 2015, the Pato Biobank that has existed since 1999 became a part of the structure.
Today Bio and Genome Bank Denmark consists of:
- Danish Cancer Biobank (DCB)
- Danish Reuma Biobank (DRB)
- Danish Genetic Biobank (DGB)
- Danish Blood Donor Biobank (DBB)
- The Pato Biobank
The biobanks are a national collaboration between (public) hospital departments.